(Q50575054)

15 March 2018

title

[Interferon-alpha and ribavirin treatment in a patient with hepatitis C virus-associated cutaneous periarteritis nodosa] (English)

1 reference

15 March 2018

1 reference

1 reference

Naouri M

1

1 reference

15 March 2018

Bacq Y

2

1 reference

15 March 2018

Machet MC

3

1 reference

15 March 2018

Rogez C

4

1 reference

15 March 2018

Machet L

5

1 reference

15 March 2018

publication date

1 August 2006

1 reference

15 March 2018

Annales de dermatologie et de vénéréologie

published in

1 reference

15 March 2018

volume

133

1 reference

15 March 2018

issue

8-9 Pt 1

1 reference

15 March 2018

page(s)

679-682

1 reference

15 March 2018

Lichen planus and hepatitis C virus: prevalence and clinical presentation of patients with lichen planus and hepatitis C virus infection

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0151-9638%2806%2970990-5

7 January 2021

Should patients with chronic hepatitis C infection be transplanted?

1 reference

https://api.crossref.org/works/10.1016%2FS0151-9638%2806%2970990-5

7 January 2021

[Vasculitis associated with viral infections]

1 reference

https://api.crossref.org/works/10.1016%2FS0151-9638%2806%2970990-5

7 January 2021

Polyarteritis nodosa after interferon treatment for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0151-9638%2806%2970990-5

7 January 2021

Manifestation of cutaneous polyarteritis nodosa during interferon therapy for chronic hepatitis C associated with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0151-9638%2806%2970990-5

7 January 2021

Necrotizing vasculitis associated with hepatitis C virus infection: successful treatment of vasculitis with interferon-alpha despite persistence of mixed cryoglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0151-9638%2806%2970990-5

7 January 2021

Hepatitis C virus infection in cutaneous polyarteritis nodosa: a retrospective study of 16 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0151-9638%2806%2970990-5

7 January 2021

Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels

1 reference

https://api.crossref.org/works/10.1016%2FS0151-9638%2806%2970990-5

7 January 2021

Cutaneous periarteritis nodosa: a clinicopathological study of 79 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0151-9638%2806%2970990-5

7 January 2021

Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0151-9638%2806%2970990-5

7 January 2021

Sustained exacerbation of cryoglobulinaemia-related vasculitis following treatment of hepatitis C with peginterferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS0151-9638%2806%2970990-5

7 January 2021

Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0151-9638%2806%2970990-5

7 January 2021

Acute exacerbation of vasculitis during interferon-alpha therapy for hepatitis C-associated cryoglobulinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0151-9638%2806%2970990-5

7 January 2021

Fatal exacerbation of hepatitis C-related cryoglobulinemia with interferon-alpha therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0151-9638%2806%2970990-5

7 January 2021

Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0151-9638%2806%2970990-5

7 January 2021

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

1 reference

https://api.crossref.org/works/10.1016%2FS0151-9638%2806%2970990-5

7 January 2021

10.1016/S0151-9638(06)70990-5

Identifiers

DOI

1 reference

15 March 2018

1 reference

15 March 2018